Genetic Variation in the Hypoxia-Inducible Factor-1α Gene Is Associated with Type 2 Diabetes in Japanese
Author(s) -
Norihiro Yamada,
Yukio Horikawa,
Naohisa Oda,
Katsumi Iizuka,
Nobuyuki Shihara,
Shoji Kishi,
Jun Takeda
Publication year - 2005
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2005-0991
Subject(s) - single nucleotide polymorphism , biology , vascular endothelial growth factor , type 2 diabetes , haplotype , endocrinology , diabetic retinopathy , linkage disequilibrium , medicine , exon , hypoxia inducible factors , neovascularization , diabetes mellitus , angiogenesis , genetics , gene , cancer research , genotype , vegf receptors
Vascular endothelial growth factor plays a critical role both in neovascularization of proliferative diabetic retinopathy and in angiogenesis of islets in the pancreatic developmental stage in determining beta-cell mass and properties. Vascular endothelial growth factor mRNA levels increase as a result of increased transcriptional activation, mediated predominantly by hypoxia-inducible factor-1 alpha (HIF-1alpha) in response to hypoxia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom